Navigation Links
First U.S. Patient to Receive New Heart-Assist Device Doing Well After Surgery at University of Michigan
Date:8/5/2008

National trial aims to help heart failure patients survive until transplant, and may offer lower clot risk and less blood damage than earlier heart devices

ANN ARBOR, Mich., Aug. 5 /PRNewswire-USNewswire/ -- Anthony Shannon made history on July 30. That's when he became the first person in the United States to receive a new type of experimental and very high-tech heart-assist device. Called a DuraHeart, it was implanted in his chest, and connected to his failing heart, to help pump his blood and keep him alive.

Shannon, a 62-year-old from Livonia, Mich., is doing well less than one week after the operation, which was performed by a team led by surgeon Francis Pagani, M.D., Ph.D. at the University of Michigan Cardiovascular Center. Shannon is the former director of homeland security and emergency management for Wayne County, Mich., and holds a Ph.D., in public administration.

The DuraHeart, made by an Ann Arbor, Mich.-based company called Terumo Heart Inc., uses advanced magnetic-levitation technology. This "maglev" approach, as it is called, means that a crucial, constantly revolving part within the hockey puck-sized implanted device never touches the walls of the pumping chamber.

Instead, it levitates in the middle, suspended in a magnetic field and pushing blood along. The battery-powered device pushes blood from the heart to the body, taking over most of the function of the left side of a severely weakened heart.

As a result, DuraHeart may cause less damage to blood cells and be less likely to allow dangerous blood clots to form, compared with other heart-assisting devices that use mechanical pumps. It has already been used in 70 patients in Europe, where it received approval for commercial use in 2007 after a clinical trial.

Now, heart failure patients at U-M and other centers across the U.S. will have the opportunity to volunteer for a clinical trial of the DuraHeart, which is being co-led by Pagani and by Yoshif
'/>"/>

SOURCE University of Michigan Health System
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
3. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
4. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
5. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
6. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
7. Tainted Chinese Food Ingredients First Discovered in 2005
8. First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial
9. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
10. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
11. Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... Nov. 24 Endologix, Inc.... treatments for aortic disorders, announced today ... all proceedings in, the patent infringement lawsu.... The motion was filed in the United States Distr...x has requested that the stay remain in effect whi...
(Date:11/24/2009)..., Nov. 24 Vermillion, In...ny filed its Plan of Reorganization and Disclosure...ed States Bankruptcy Court for the District of Del...osure Statement is presently scheduled for Decembe... the Plan scheduled for January 7, 2010. ,, Th...
(Date:11/24/2009)...E, N.J. and NEW YORK, Nov. 24 Ei....S. Food and Drug Administration (FDA) has accepte...r once daily 23 mg Aricept® (donepezil HCl ex...ate to severe Alzheimer,s disease (AD). This new ...l HCl in an extended release, matrix-type tablet w...
Breaking Medicine Technology:Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3Vermillion Files Plan of Reorganization 4FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 2FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 3New study expands the list of hazardous chemicals in smokeless tobacco 54592 1New study expands the list of hazardous chemicals in smokeless tobacco 54592 2Health reform proposals could help 13 million uninsured young adults gain coverage 54588 1Health reform proposals could help 13 million uninsured young adults gain coverage 54588 2Health reform proposals could help 13 million uninsured young adults gain coverage 54588 3International Travel Health Guidebook Gets Updated 54583 1International Travel Health Guidebook Gets Updated 54583 2
...y to experience a fracture , , WOONSOCKET, R.I.,...: CVS ) indicates that 87 percent of women 18 ye... drug therapy to treat the disease, did not experi...The CVS Caremark data also found that those women ...re not on therapy were 5.7 times more likely to ex...
... the nation,s largest independent behavioral healt...the use of The Joint Commission,s Hospital-Based I...measures. The basis for the recently completed pil...nce measures to help patients receive the most app...chiatric inpatient services and for services upon ...
Other Medicine Technology:CVS Caremark Data Confirms Improved Outcomes for Women with Osteoporosis Who are Adherent to Therapy 2CVS Caremark Data Confirms Improved Outcomes for Women with Osteoporosis Who are Adherent to Therapy 3ValueOptions(R) Supports New Hospital-Based Performance Measures to Help Patients Get the Best Treatment for Inpatient and Outpatient Services 2
(Date:11/27/2009)...mission vehicles may reduce future disease burden,...althDay News) -- Encouraging city dwellers to walk...h greater public health benefits than increased us... found. , The study compared the projected heal...port scenarios for London, England, and Delhi, Ind...
(Date:11/27/2009)...i-purpose bilingual coloring books designed for ch...ess community to educate - inform parents and chil...sues to Dinosuars to ABC,S and a host of other top...RWEB) November 27, 2009 -- Today’s children ...hem busy any hour of the day, but one of the oldes...
(Date:11/26/2009)... Nov. 27 The diabetes population i...xt 25 years and annual medical spending on the dis...3 billion today, according to a study published in...nal Changing Diabetes ® Program (NCDP), a pr...y a team from the University of Chicago. ,, Acc...
(Date:11/26/2009)...on an emotional rollercoaster, study finds , ...it the fear factor meets the jubilant sports fan. ...ially those who root for the winning team -- enjoy...sted match and victory was in doubt, producing fee... this Thanksgiving weekend as you,re glued to the ...
(Date:11/26/2009)...on Communications announces a highly effective and...rs struggling to make an economic recovery. , ...Flu fears is the type of challenge that could send...ding to Dr. David Benton, business growth expert a...stem – The Rfactor Intensive . “Fea...
Breaking Medicine News(10 mins):Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 4Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Pharmacist Injects Cure for Ailing Businesses 2
...ers in Australia have been accused of using privat...le not passing on cost increases to hospitals // ....gain asked Federal Health Minister Tony Abbott las...ouble the inflation rate. The nation's biggest...
...apy is a very old way of treating psychological di...ty years ago // . There has been lot of questi...that made the psychologist to view problems of the...idely accepted by many psychologists. In t...
...rvous system gets affected by rabies which is tran.... Immediate medical attention // is required for ... or raccoon which is rabid. If bite from an animal...stantly. The bite injury should be washed th...
... 9-year-old Chinese boy against a local health age...in favor of the health concern // , much to the di...rs. The boy is said to have contracted the v...d the infected blood product. Both parents have be...
...onals in New Zealand are seeking legal protection ...n the country, when they would be compelled to wor...nal health and safety (OSH) regulations in force i...there is an acute shortage of medical professional...
...developer Peplin has said that it would speed up t...cer cream since it was able to get an amount of $1...purpose. The company based in Queensland, Au...scription to your pharmacist, you’ll get it filled...
Other Medicine News:Health News:Australian Health funds stand accused 2Health News:Boy Refused Compensation For HIV Infection Following Hospital Admission 2
...vacuum stage, porous vacuum plate, reservoir seal ...d, instructions. The Model 785 vacuum blotter qui...agarose gel onto a nylon membrane. Because it gene...ic acid samples can be separated on a gel, transfe...
...r, base with vacuum stage, porous vacuum plate, re...w gaskets, lid, instructions. The Model 785 vacuu... RNA from an agarose gel onto a nylon membrane. Be...er, the nucleic acid samples can be separated on a...
Hoefer miniVE, Complete
Hoefer Blot module
Medicine Products: